Transplant Connect to Expand Human Biologics Management Software with Investment from InVita Healthcare Technologies |

LOS ANGELES, January 18, 2022 /CNW/ – Transplant Connect, the world’s leading provider of donation and transplantation software, is pleased to announce an investment from InVita Healthcare Technologies. InVita provides leading chain of custody software for complex medical environments including blood, plasma, tissue, implants and forensic DNA. This strategic investment will help accelerate the continued expansion of Transplant Connect iTransplantation℠ clinical information, communication, analysis and logistics platform and its many innovations, such as the iReferral℠ automated donor referral technology.

“We welcome Transplant Connect and its world-class products to InVita’s strong portfolio serving complex medical environments,” said Todd Collins, President and CEO of InVita. “Software that manages critical operations, such as organ, tissue, eye and human tissue donation and transplantation, is a natural fit for InVita. This investment reinforces our mission to provide the most innovative and comprehensive solutions for managing complex medical workflows. We are proud to work with the leader in this field.”

the iTransplantation℠ The platform supports nearly 75% of all deceased organ, tissue and eye donations in United States and is used by over 12,500 healthcare professionals in over 100 organ, tissue, eye and birth tissue organizations worldwide.

“We are really excited about this investment from InVita,” said John Piano, Founder, President and CEO, Transplant Connect. “Through this investment, we will be able to expand our life-saving resources and capabilities and significantly scale our innovation, enabling us to further connect the donation and transplantation ecosystem and help save and to heal more lives in the United States and around the world. Our combined resources will allow us to build on the unprecedented success of Transplant Connect for more than 17 years and take our offerings to the next level.”

About InVita Healthcare Technologies

InVita provides chain of custody software technologies for complex medical, forensic and community care environments. InVita’s solutions optimize supply chains, sample tracking, and visibility into blood and plasma operations, tissue and implant lifecycles, and environments spanning DNA and forensics. InVita’s solutions help increase compliance and cost control, reduce risk and improve patient and public safety outcomes.

About Transplant Connect

Founded in 2004 as a mission-driven medical software company, Transplant Connect is the world’s leading provider of human biological donation and transplantation software (organs, tissues, eyes, placenta and more). Included in the company’s growing suite of solutions are iTransplantation℠, a secure cloud platform for clinical management, communications, analytics, and logistics, and iReferral℠, the first and only automated donor referral technology available to hospitals, medical examiners/coroners, organ procurement agencies, tissue banks and eye banks.

Show original content to download multimedia:https://www.prnewswire.com/news-releases/transplant-connect-to-expand-human-biologics-management-software-with-investment-from-invita-healthcare-technologies-301463355.html

SOURCE graft connection

Comments are closed.